News

Bliss GVS Pharma Limited announced that its ESOP Allotment Committee approved the allotment of 53,500 equity shares to eligible employees under the Bliss GVS Pharma Limited – Employee Stock Option Plan 2019, increasing the company`s issued, subscribed, and paid-up share capital from 10,63,30,473 equity shares aggregating Rs 10,63,30,473 to 10,63,83,972 equity shares aggregating Rs 10,63,83,972.

Bliss GVS Pharma Limited submitted a certificate to the National Stock Exchange of India Limited and BSE Limited under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, its Registrar and Share Transfer Agent.

Bliss GVS Pharma Limited will close its trading window for insiders, designated persons, and their immediate relatives starting October 1, 2026, and continuing until 48 hours after the announcement of the company’s unaudited financial results for the quarter and half year ended September 30, 2026, as per Securities Exchange Board of India regulations.

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2026.

Bliss GVS Pharma announced that the 41th Annual General Meeting(AGM) of the company will be held on 15 July 2026.